JPMORGAN CHASE & CO - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 87 filers reported holding FORTRESS BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q3 2023$2,935
-47.2%
10,1100.0%0.00%
Q2 2023$5,561
-30.5%
10,1100.0%0.00%
Q1 2023$8,000
+114185.7%
10,1100.0%0.00%
Q4 2022$7
-99.9%
10,1100.0%0.00%
Q3 2022$9,000
+12.5%
10,1100.0%0.00%
Q2 2022$8,000
-86.9%
10,110
-77.3%
0.00%
Q1 2022$61,000
-39.0%
44,523
+11.2%
0.00%
Q4 2021$100,000
-26.5%
40,034
-5.2%
0.00%
Q3 2021$136,000
-51.9%
42,232
-46.5%
0.00%
Q2 2021$283,000
-51.0%
78,992
-51.7%
0.00%
Q1 2021$577,000
+16.1%
163,519
+4.3%
0.00%
Q4 2020$497,000
+153.6%
156,782
+210.9%
0.00%
Q3 2020$196,000
+28.1%
50,428
-11.8%
0.00%
Q2 2020$153,000
+194.2%
57,154
+107.8%
0.00%
Q1 2020$52,000
+92.6%
27,501
+165.6%
0.00%
Q4 2019$27,000
+92.9%
10,355
+3.6%
0.00%
Q3 2019$14,000
-6.7%
10,000
+17.2%
0.00%
Q1 2019$15,000
+50.0%
8,534
-26.0%
0.00%
Q4 2018$10,000
-96.9%
11,526
-94.3%
0.00%
Q3 2018$321,000
+94.5%
200,886
+264.5%
0.00%
Q2 2018$165,000
+66.7%
55,120
+151.7%
0.00%
Q1 2018$99,000
+253.6%
21,896
+208.0%
0.00%
Q4 2017$28,000
-66.7%
7,109
-68.6%
0.00%
Q1 2017$84,00022,6110.00%
Other shareholders
FORTRESS BIOTECH INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,000,000$580,6000.19%
Nantahala Capital Management 6,018,211$1,747,0870.15%
THOMPSON DAVIS & CO., INC. 12,996$3,7730.01%
Platform Technology Partners 30,000$8,7090.00%
Black Maple Capital Management LP 15,000$4,3550.00%
Arete Wealth Advisors, LLC 52,547$15,2540.00%
B. Riley Wealth Advisors, Inc. 144,700$42,0060.00%
ACADIAN ASSET MANAGEMENT LLC 1,075,531$3110.00%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 1,542,000$447,6430.00%
GROUP ONE TRADING, L.P. 2,000$5810.00%
View complete list of FORTRESS BIOTECH INC shareholders